Horizon Therapeutics HZNP reported its Q3 earnings results on Wednesday, November 2, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Horizon Therapeutics beat estimated earnings by 23.76%, reporting an EPS of $1.25 versus an estimate of $1.01.
Revenue was down $111.64 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.28 which was followed by a 0.06% increase in the share price the next day.
Here's a look at Horizon Therapeutics's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | 1.35 | 1.20 | 1.34 | 1.54 |
| EPS Actual | 1.07 | 1.34 | 1.41 | 1.75 |
| Revenue Estimate | 936.10M | 874.41M | 995.87M | 979.41M |
| Revenue Actual | 876.41M | 885.25M | 1.01B | 1.04B |
To track all earnings releases for Horizon Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.